Shenzhen-based artificial intelligence biotech start-up XtalPi has raised US$46 million in series B+ financing round led by China Life Healthcare Fund.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?